Targeted Radionuclide Therapy
Radioimmunotherapy, also known as systemic targeted radiation therapy, uses antibodies, antibody fragments, or
compounds as carriers to guide radiation to the targets. It is a topic rapidly increasing in importance and success in
treatment of cancer patients. This book represents a comprehensive amalgamation of the radiation physics, chemistry,
radiobiology, tumor models, and clinical data for targeted radionuclide therapy. It outlines the current challenges and
provides a glimpse at future directions. With significant advances in cell biology and molecular engineering, many
targeting constructs are now available that will safely deliver these highly cytotoxic radionuclides in a targeted
fashion.
A companion website includes the full text and an image bank.